We are live on ! Find out more
GCM

Ghisallo Capital Management Portfolio holdings

AUM $3.63B
1-Year Est. Return 30.51%
This Fund
S&P 500
This Quarter Est. Return
-0.22%
1 Year Est. Return
+30.51%
3 Year Est. Return
+102.79%
5 Year Est. Return
+106.47%
10 Year Est. Return
AUM
$2.63B
AUM Growth
+$1.35M
Cap. Flow
+$154M
Cap. Flow %
5.85%
Top 10 Hldgs %
23.88%
Holding
517
New
128
Increased
23
Reduced
94
Closed
61

Sector Composition

Rank Sector Weight
1 Technology 24.23%
2 Financials 19.42%
3 Consumer Discretionary 18.8%
4 Healthcare 10.16%
5 Real Estate 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNCY
401
DELISTED
Sun Country Airlines
SNCY
$503K 0.02%
15,000
-235,000
-94% -$7.83M
SLAC
402
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
$489K 0.02%
50,000
VAQC
403
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$486K 0.02%
262,500
VTIQ
404
DELISTED
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
$486K 0.02%
50,000
GSL icon
405
Global Ship Lease
GSL
$1.47B
$474K 0.02%
20,000
-212,691
-91% -$4.26M
LTHM
406
DELISTED
Livent Corporation
LTHM
$462K 0.02%
20,000
-730,000
-97% -$16.4M
LU icon
407
Lufax Holding
LU
$1.4B
$454K 0.02%
16,250
-393,887
-96% -$13.1M
MCB icon
408
Metropolitan Bank Holding Corp
MCB
$1.15B
$422K 0.02%
+5,000
New +$364K
PLTK icon
409
Playtika
PLTK
$1.03B
$414K 0.02%
15,000
-170,874
-92% -$4.25M
TMCI icon
410
Treace Medical Concepts
TMCI
$304M
$404K 0.02%
15,000
-135,000
-90% -$3.71M
MTLS
411
Materialise
MTLS
$396M
$402K 0.02%
20,000
-635,594
-97% -$13.9M
IMRX icon
412
Immuneering
IMRX
$312M
$398K 0.02%
+15,000
New +$403K
VOSO
413
DELISTED
Virtuoso Acquisition Corp. Class A Common Stock
VOSO
$396K 0.02%
40,000
IPSC icon
414
Century Therapeutics
IPSC
$353M
$377K 0.01%
15,000
-15,000
-50% -$406K
ABR icon
415
Arbor Realty Trust
ABR
$1.01B
$371K 0.01%
20,000
-280,000
-93% -$5.06M
FRSG
416
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
$371K 0.01%
37,500
MAXN
417
DELISTED
Maxeon Solar Technologies
MAXN
$353K 0.01%
200
-2,461
-92% -$4.21M
SOPH icon
418
SOPHiA GENETICS
SOPH
$644M
$351K 0.01%
+20,000
New +$352K
GLUE icon
419
Monte Rosa Therapeutics
GLUE
$1.34B
$334K 0.01%
15,000
-5,000
-25% -$143K
BRNS
420
Barinthus Biotherapeutics
BRNS
$23.5M
$325K 0.01%
20,625
+10,625
+106% +$161K
VZIO
421
DELISTED
VIZIO Holding Corp.
VZIO
$319K 0.01%
15,000
-35,000
-70% -$765K
TNYA icon
422
Tenaya Therapeutics
TNYA
$169M
$310K 0.01%
+15,000
New +$322K
AMRS
423
DELISTED
Amyris Inc.
AMRS
$275K 0.01%
20,000
-292,305
-94% -$4.18M
ACVA icon
424
ACV Auctions
ACVA
$1.28B
$268K 0.01%
15,000
-35,000
-70% -$743K
CYT
425
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$263K 0.01%
15,000
-10,000
-40% -$187K

Similar funds

Ghisallo Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Ghisallo Capital Management held 517 positions worth $2.63B, up 0.05% from $2.63B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Ghisallo Capital Management deployed $154M of net new capital in Q3 2021, opening 128 new positions and adding to 23 existing holdings. Its largest new stake was Coupang: 3,786,356 shares worth $105M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was XPO, an estimated $49M trimmed.

  • Ghisallo Capital Management's largest Q3 2021 buy was Coupang: 3,786,356 shares worth $105M.
  • Ghisallo Capital Management added most to Maravai LifeSciences in Q3 2021, an estimated $57.7M increase.
  • Ghisallo Capital Management's biggest Q3 2021 reduction was XPO, cutting an estimated $49M.
  • Ghisallo Capital Management fully exited Keurig Dr Pepper in Q3 2021, selling an estimated $70.5M.
  • Ghisallo Capital Management's ten largest holdings make up 24% of its $2.63B portfolio in Q3 2021.
  • Ghisallo Capital Management opened 128 new positions and closed 61 in Q3 2021.
  • Ghisallo Capital Management's portfolio value rose 0.05% quarter-over-quarter to $2.63B.

Based on Ghisallo Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.